Related references
Note: Only part of the references are listed.Simultaneous determination of irbesartan and hydrochlorothiazide in human plasma by ultra high performance liquid chromatography tandem mass spectrometry and its application to a bioequivalence study
Xiangjun Qiu et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2014)
Inhibition of the organic anion-transporting polypeptide 1B1 by quercetin: an in vitro and in vivo assessment
Lan-Xiang Wu et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug-Drug Interactions
Maria Karlgren et al.
PHARMACEUTICAL RESEARCH (2012)
The Influence of MDR1 G2677T/A Genetic Polymorphisms on the Pharmacokinetics of Repaglinide in Healthy Chinese Volunteers
Qian Xiang et al.
PHARMACOLOGY (2012)
Effects of natural products on the function of human organic anion transporting polypeptide 1B1
Lan-Xiang Wu et al.
XENOBIOTICA (2012)
Rifampin Enhances the Glucose-Lowering Effect of Metformin and Increases OCT1 mRNA Levels in Healthy Participants
S. K. Cho et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Effects of SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of repaglinide in healthy Chinese volunteers
Jiake He et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Repaglinide-gemfibrozil drug interaction: inhibition of repaglinide glucuronidation as a potential additional contributing mechanism
Jinping Gan et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Effects of gemfibrozil and atorvastatin on the pharmacokinetics of repaglinide in relation to SLCO1B1 polymorphism
A. Kalliokoski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Effects of the SLCO1B1*1B haplotype on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide
Annikka Kalliokoski et al.
PHARMACOGENETICS AND GENOMICS (2008)
Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1
Stefan Oswald et al.
PHARMACOGENETICS AND GENOMICS (2008)
Effect of SLCO1B1 genetic polymorphism on the pharmacokinetics of nateglinide
Wei Zhang et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Drug-drug interaction between pitavastatin and various drugs via OATP1B1
Masaru Hirano et al.
DRUG METABOLISM AND DISPOSITION (2006)
Drug and bile acid transporters in rosuvastatin hepatic uptake: Function, expression, and pharmacogenetics
Richard H. Ho et al.
GASTROENTEROLOGY (2006)
Organic anion transporting polypeptide 1B1 activity classified by SLCO1B1 genotype influences atrasentan pharmacokinetics
DA Katz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Flavonoids as a novel class of human organic anion-transporting polypeptide OATP1B1 (OATP-C) modulators
XD Wang et al.
DRUG METABOLISM AND DISPOSITION (2005)
Metabolism of repaglinide by CYP2C8 and CYP3A4 in vitro:: Effect of fibrates and rifampicin
LI Kajosaari et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2005)
Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells
Y Kameyama et al.
PHARMACOGENETICS AND GENOMICS (2005)
Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics
M Niemi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Effect of genetic polymorphisms in cytochrome P450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs - Clinical relevance
J Kirchheiner et al.
CLINICAL PHARMACOKINETICS (2005)
High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)
M Niemi et al.
PHARMACOGENETICS (2004)
Functional analysis of single nucleotide polymorphisms of hepatic organic anion transporter OATP1B1 (OATP-C)
M Iwai et al.
PHARMACOGENETICS (2004)
CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide
TB Bidstrup et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation
RG Tirona et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Clinical pharmacokinetics and pharmacodynamics of repaglinide
V Hatorp
CLINICAL PHARMACOKINETICS (2002)
Share Paper
